XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results | British Journal of Cancer
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer | British Journal of Cancer
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials - The Lancet Oncology
Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice - ScienceDirect
3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
Figure 2 from The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels | Semantic Scholar
Median cycle of XELOX adjuvant chemotherapy received by patients for... | Download Scientific Diagram
Table 1 from The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels | Semantic Scholar
Adjuvant treatment for colon cancer. | Download Scientific Diagram
Kaplan–Meier curves of patients with stage III colon cancer in right-... | Download Scientific Diagram
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer | NEJM
PPT - ESMO/ECCO Presidential Session III PowerPoint Presentation, free download - ID:5764158
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial - ScienceDirect
CAPOX - Wikipedia
Cancers | Free Full-Text | The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
The prognostic effect of adjuvant chemotherapy in the colon cancer patients with solitary lymph node metastasis | International Journal of Colorectal Disease
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient
Adjuvant Therapy for Locoregional Colon Cancer (Slides With Transcript)
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer | NEJM
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience | Cancer Communications | Full Text
Adjuvant chemotherapy for colorectal cancer - ScienceDirect
Proposed decision algorithm for adjuvant therapy in colon cancer LN:... | Download Scientific Diagram
Oral adjuvant therapy for colorectal cancer: recent developments and future targets | Therapeutic Delivery
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience | Cancer Communications | Full Text
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial - The Lancet Oncology
4. Cancer colorectal métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
